Q4 2024 Holdings
Filed 2025-02-14 | 51 holdings | $355.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Icon PLC(ICLR) | SHS | G4705A100 | $41.0M | 195,500 | 11.5% |
| Maximus Inc(MMS) | COM | 577933104 | $28.5M | 381,423 | 8.0% |
| The Cigna Group(CI) | COM | 125523100 | $27.1M | 98,003 | 7.6% |
| Labcorp Holdings Inc(LH) | COM SHS | 504922105 | $26.0M | 113,293 | 7.3% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $18.7M | 387,000 | 5.3% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $18.5M | 174,811 | 5.2% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $16.3M | 451,793 | 4.6% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $13.2M | 2,370,000 | 3.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.1M | 2,367,007 | 3.4% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $11.9M | 66,772 | 3.3% |
| Viatris Inc(VTRS) | COM | 92556V106 | $9.1M | 730,000 | 2.6% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $9.0M | 606,410 | 2.5% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $8.9M | 4,046,797 | 2.5% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $8.8M | 160,051 | 2.5% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $8.8M | 425,574 | 2.5% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $7.7M | 1,054,651 | 2.2% |
| Vaxart Inc(VXRT) | COM NEW | 92243A200 | $7.6M | 11,515,315 | 2.1% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $7.6M | 1,437,500 | 2.1% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $6.8M | 473,292 | 1.9% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $6.7M | 636,300 | 1.9% |
| Septerna Inc(SEPN) | COM | 81734D104 | $6.2M | 271,687 | 1.8% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $5.4M | 2,054,593 | 1.5% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $5.4M | 3,572,167 | 1.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.7M | 73,511 | 1.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.5M | 504,887 | 1.3% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $4.0M | 907,783 | 1.1% |
| Artivion Inc(AORT) | COM | 228903100 | $3.5M | 121,178 | 1.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $3.4M | 1,356,186 | 1.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $3.3M | 240,870 | 0.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $3.2M | 123,000 | 0.9% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $2.6M | 434,700 | 0.7% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $2.4M | 697,413 | 0.7% |
| Tela BIO Inc(TELA) | COM | 872381108 | $1.9M | 630,000 | 0.5% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $1.8M | 668,115 | 0.5% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.4M | 1,328,352 | 0.4% |
| Alector Inc(ALEC) | COM | 014442107 | $1.2M | 615,628 | 0.3% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.0M | 177,004 | 0.3% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $933.7K | 1,000,000 | 0.3% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $910.0K | 276,603 | 0.3% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $574.3K | 121,672 | 0.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $558.0K | 155,000 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $530.9K | 71,458 | 0.1% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $470.0K | 162,058 | 0.1% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $406.7K | 50,839 | 0.1% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $345.2K | 251,990 | 0.1% |
| Mesoblast LTD(MESO) | SPONS ADR | 590717401 | $229.7K | 11,600 | 0.1% |
| Nextcure Inc | COM | 65343E108 | $100.2K | 130,000 | 0.0% |
| Humacyte Inc | *W EXP 08/27/202 | 44486Q111 | $91.7K | 49,998 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $55.4K | 10,000 | 0.0% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $15.4K | 400,000 | 0.0% |